Effectiveness of antianemic therapy for patients with severe iron deficiency anemia

Abstract

Aim. To assess the effectiveness of antianemic therapy in patients with severe iron deficiency anemia.Material and Methods. For inpatient treatment, 30 patients with severe iron deficiency anemia, who exhibited significant cardiovascular system disturbances in the form of developed cardiomyopathy of anemic origin, were selected.Results and discussion. Therefore, the therapy conducted on average contributes to an increase in hemoglobin level by 5.0-6.0 g/l, serum iron by 1.25 µmol/l, and erythrocytes up to 4.0±0.03. In addition to the pronounced clinical effect, patients showed an increase in hemoglobin levels from 75.0±4.5 g/l to 95.0±5.0 g/l. The content of total lipids did not change significantly.Conclusion. The treatment course conducted in patients with severe forms of anemia was found to contribute to an increase in the number of erythrocytes, and levels of hemoglobin, hematocrit, serum iron, and ferritin. This suggests its effectiveness and safety as a treatment method for patients with iron deficiency anemia in the context of developed cardiomyopathy of anemic origin.